With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Other experts believe that they’re two distinct conditions. Treatment for perioral dermatitis can vary depending on how severe it is and how often it reoccurs. The American Osteopathic College ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...

If someone has atopic dermatitis during childhood, it’s likely they’ll have recurrent flares and need recurrent treatment. However, parents can help minimize their child’s flares by ...